UN backed group sub-licence drug
Pfizer has agreed to allow companies to make a generic version of its Covid treatment pill.
Data from the company says it reduces the risk of hospitalisation by 89 per cent.
The licensing agreement with the Medicines Patent Pool was announced today, and allows the UN backed group to issue sub-licences.
The drug will be administered alongside Ritanovir, which is widely used to treat HIV.

Pitbull Fans Set Bald Cap World Record In London
Ceasefire Under Threat As US Attack Iran Overnight
Nigel Farage To Resign As MP And Run In By-Election
MEPs Meeting This Morning To Discuss Ireland's EU Presidency
Member States Responsible For Suspending EU Trade Agreement With Israel - Von Der Leyen
€4.1BN Fine Upheld Against Google For Anti-Competitive Practices
"Massive" Russian Strikes In Kyiv Overnight Kills 13 People